ArticleThe New phytologist2026
ESN3, a nodule-specific small peptide essential for symbiotic nitrogen fixation in Medicago truncatula.
Article in The New phytologist, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Symbiotic interactions between legumes and rhizobia rely on the symbiotic interface, the symbiosome membrane. However, the regulatory mechanisms for symbiosome membrane maintenance remain largely elusive. Methods include forward genetics screenings of mutants, transcript-based cloning and genetic complementation, yeast two-hybrid library screening and Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated protein 9 gene editing. We characterized Early Senescent Nodule 3 (ESN3), a key regulator of symbiotic nitrogen fixation (SNF) encoding a nodule-specific, 54 aa-long small peptide, which localizes to the symbiosome membrane in Medicago truncatula. We identified SYPTAXIN132 as an ESN3-interacting protein. We showed that syp132a mutants exhibited premature nodule senescence and upregulation of senescence-associated gene expression, similar to the esn3 mutant. Our proteomic studies revealed significant alterations of a large number of membrane proteins in the symbiosome fraction of the esn3 mutant, consistent with a key role of ESN3 in symbiosome maintenance. Furthermore, our data indicated that the expression of ESN3, but not SYP132A, is responsive to gibberellic acid (GA) treatments and DELLA proteins are positive regulators of ESN3 gene expression. In this study, we demonstrated that ESN3 encodes a novel nodule-specific small peptide, playing a key role in SNF. In conjunction with the syntaxin SYP132A, GA signaling plays a negative role in SNF at a later stage of nodule development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.